Blood cells from an 80-year-old donor were converted in a lab dish into neural stem cells whose epigenetic clocks read a molecular age of less than 20. The conversion came from a team at the University Hospital Bonn, the University of Bonn and RWTH Aachen University in Germany.
Help yourself and the planet: The Cool Down makes it easy to help yourself while helping the planet, with smart, simple changes to save more and waste less in your everyday life.
We may earn a commission if you sign up.
Oliver Brüstle, director of the Institute of Reconstructive Neurobiology at the University Hospital Bonn, led the work, which was reported in the journal Aging Cell. It is a cell-culture result, offered as a research model, and not a way of making living people younger.
Red blood cell precursors turned directly into neural stem cells
The starting material was immature red blood cell precursors taken from the 80-year-old. According to ScienceDaily’s Oct. 21 report on the study, the researchers used transcription factors, proteins that switch genes on and off, to reprogram those cells straight into neural stem cells. Earlier approaches typically sent cells back through a pluripotent stem cell stage first. Skipping that step is the technical point of the method. Brüstle described it in the university’s account, saying the team had “directly converted red blood cell precursors into neural stem cells.”
The paper is titled “Protracted Fate Acquisition and Epigenetic De-Aging During Induced Neural Stem Cell Conversion of Human Blood Cells” and carries DOI 10.1111/acel.70751. Its authors are Lea Jessica Berg, Julia Franzen, Andreas Buness, Rachel Konang, Chao Sheng, Michael Peitz, Andreas Till, Wolfgang Wagner and Brüstle.
Epigenetic clocks and the under-20 reading
Biological age in the study was not judged by how the cells looked but by epigenetic clocks, which estimate age from chemical marks on DNA that shift over a lifetime without altering the genetic sequence itself. By that measure the cells derived from the 80-year-old carried signatures corresponding to an age below 20. The report describes roughly 60 years of rejuvenation after 50 days, which is where the broader headline about reversing six decades of aging comes from.
The University of Bonn’s own release, dated Oct. 9, adds a note of restraint. A molecular age under 20 describes a pattern of DNA marks, and the researchers present their belief that such epigenetic rejuvenation makes cells behave like young cells as an expectation, not a demonstrated mechanism. The release also shows the work was tested in a dish only, with no rejuvenation measured in a living organism.
Why a slow rewind is useful for Alzheimer’s research
Many reprogramming methods rewind cells abruptly, which makes it hard to see what is going on in between. Here the change was slow. Brüstle said that “rejuvenation occurred gradually and could be tracked for over 100 days.” He called a process that stretches over so long a period “ideal as an experimental model,” because researchers can look for the factors that speed up or slow down the reset. Those factors have not yet been identified.
The link to disease runs through age itself. Brüstle noted that age is the most important risk factor for neurodegenerative diseases such as Alzheimer’s, so a human-derived cell model in which age can be dialed back and tracked gradually could help separate what aging does to neural cells from what disease does. The team’s earlier work had already shown that nerve cells made with this kind of direct conversion could connect with existing neurons after being transplanted into mouse brains, according to the Bonn report. That earlier line of research is documented in a paper on stably self-renewing adult blood-derived induced neural stem cells that exhibit epigenetic rejuvenation.
The new study itself does not put such cells into animals or people. Funding came from the European Union’s Horizon 2020 program, the German Research Foundation and Germany’s federal research ministry, and the authors describe the result as a laboratory model rather than a therapy. They suggest it could help researchers study how aging connects to Alzheimer’s disease, and that is the extent of the clinical claim; no treatment, trial or timeline is attached to the work, and none should be inferred from the age reading alone.
What the result does and does not show
For readers wondering whether this means older people could be made biologically younger, the answer from the source material is no. The cells were a purified, engineered population grown in culture, and the clock reading says nothing about an entire body, its organs or its immune system. The same Bonn group has also worked with stem cells from a 101-year-old donor, according to image captions in its release, which suggests the approach is not limited to one individual, but the study reports its headline result for the 80-year-old donor.
Independent coverage of the Bonn release, including a News-Medical summary of the test-tube rejuvenation, repeats the same boundaries. What remains to be shown is whether the rejuvenated cells keep their young behavior over time, what drives the slow reset, and whether any of it holds in the more complex setting of a living brain.
This article was produced with the assistance of AI and reviewed by Morning Overview editors prior to publication.
Help yourself and the planet: Get The Cool Down →
We may earn a commission if you sign up.
More from Morning Overview
- Doctors warn a silent liver disease now affects one in three American adults
- The FBI told the rest of ShinyHunters to surrender after a 24-year-old was arrested
- Two passengers died at an Ohio toll plaza, and the NTSB now wants the cash lanes shut
- Long use of a common prostate pill is tied to a higher chance of glaucoma
